| Toll‐Like Receptor‐Based Strategies for Cancer Immunotherapy S Pahlavanneshan, A Sayadmanesh, H Ebrahimiyan, M Basiri Journal of Immunology Research 2021 (1), 9912188, 2021 | 69 | 2021 |
| Survivin and autoimmunity; the ins and outs H Ebrahimiyan, S Aslani, N Rezaei, A Jamshidi, M Mahmoudi Immunology letters 193, 14-24, 2018 | 59 | 2018 |
| Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages H Ebrahimiyan, A Tamimi, B Shokoohian, N Minaei, A Memarnejadian, ... International Immunopharmacology 106, 108587, 2022 | 30 | 2022 |
| microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients H Ebrahimiyan, N Rezaei, M Vojdanian, S Aslani, A Jamshidi, ... International Journal of Rheumatic Diseases 22 (6), 1107-1114, 2019 | 19 | 2019 |
| microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients H Ebrahimiyan, F Gharibdoost, S Aslani, H Kavosi, F Farsad, A Jamshidi, ... Modern Rheumatology 30 (5), 862-869, 2020 | 12 | 2020 |
| Studying the association between STAT4 gene polymorphism and susceptibility to rheumatoid arthritis disease: An updated meta-analysis H Ebrahimiyan, S Mostafaei, S Aslani, A Jamshidi, M Mahmoudi Iranian Journal of Immunology 16 (1), 71-83, 2019 | 12 | 2019 |
| Association study between STAT4 polymorphisms and susceptibility to systemic lupus erythematosus disease: A systematic review and meta-analysis H Ebrahimiyan, R Rezaei, S Mostafaei, S Aslani, GN Goulielmos, ... Meta Gene 16, 241-247, 2018 | 10 | 2018 |
| Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis H Ebrahimiyan, S Mostafaei, S Aslani, ST Faezi, E Farhadi, A Jamshidi, ... Clinical and experimental medicine, 1-12, 2022 | 6 | 2022 |
| Application of Genome-Editing Technologies for Off-the-Shelf T Cell-Based Cancer Immunotherapy Z Hakakzadeh, V Yekehfallah, H Ebrahimiyan, A Sayadmanesh, M Basiri Precision Medicine and Clinical OMICS 1 (1), 2021 | 1 | 2021 |
| miRNAs and rheumatoid arthritis: new update in expression pattern and pathogenicity H Ebrahimiyan, A Ahmadzadeh Rheumatology Research, 2021 | 1 | 2021 |
| Interferon regulatory factor 5 in Rheumatoid arthritis and systemic lupus erythematosus H Ebrahimiyan, Z Bagheri-Hosseinabadi, M Abbasifard Rheumatology Research 6 (1), 1-13, 2021 | 1 | 2021 |
| Engineering CD3 Subunits with Endoplasmic Reticulum Retention Signal Facilitates Allogeneic CAR T Cell Production H Ebrahimiyan, A Sayadmanesh, M Hesaraki, M Ebrahimi, H Baharvand, ... bioRxiv, 2024.09. 22.614328, 2024 | | 2024 |
| TP53 Gene Polymorphism (Rs1042522) in Rheumatoid Arthritis and Systemic Lupus Erythematosus: An Updated Systematic Review and Meta-Analysis H Ebrahimiyan, E Madreseh, M Akhtari, E Farhadi, A Jamshidi, ... Current rheumatology reviews, 0 | | |
Mahdi MahmoudiTehran University of Medical Sciences在 tums.ac.ir 的电子邮件经过验证
